DexCom Inc (DXCM)
Payables turnover
Dec 31, 2024 | Dec 31, 2023 | Dec 31, 2022 | Dec 31, 2021 | Dec 31, 2020 | ||
---|---|---|---|---|---|---|
Cost of revenue | US$ in thousands | 1,567,300 | 1,333,400 | 1,026,700 | 768,000 | 646,600 |
Payables | US$ in thousands | — | — | — | — | — |
Payables turnover | — | — | — | — | — |
December 31, 2024 calculation
Payables turnover = Cost of revenue ÷ Payables
= $1,567,300K ÷ $—K
= —
The payables turnover ratio for DexCom Inc has been consistently unavailable ("—") for the years 2020 to 2024 based on the provided data. The lack of this ratio makes it challenging to evaluate how efficiently the company pays its suppliers with the information at hand. To derive further insights or make relevant comparisons, additional financial data or context regarding the company's accounts payable and cost of goods sold would be necessary.
Peer comparison
Dec 31, 2024
Company name
Symbol
Payables turnover
DexCom Inc
DXCM
—
3M Company
MMM
5.43
Artivion Inc
AORT
—
Baxter International Inc
BAX
—
Becton Dickinson and Company
BDX
9.39
Boston Scientific Corp
BSX
—
Embecta Corp
EMBC
5.72
Glaukos Corp
GKOS
29.35
Globus Medical
GMED
—
Haemonetics Corporation
HAE
16.02
ICU Medical Inc
ICUI
—